# Aortic Arch Related Cerebral Hazard Trial (ARCH)

> **NCT00235248** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 350 (actual)

## Conditions studied

- Brain Infarction
- Transient Ischemic Attack
- Embolism

## Interventions

- **DRUG:** Warfarin
- **DRUG:** Clopidogrel-aspirin

## Key facts

- **NCT ID:** NCT00235248
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2010-12
- **Final completion:** 2012-07
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2012-07-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235248, "Aortic Arch Related Cerebral Hazard Trial (ARCH)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00235248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*